Respiratory syncytial virus (RSV) is a major cause of illness in young children and is the leading reason why infants are hospitalized. Until recently, this viral infection was difficult to prevent or ...
GSK boss Emma Walmsley (pictured) has been pushing to boost the firm's drug pipeline after splitting off its consumer health ...
Editorial writers discuss the RSV vaccine, sickle cell treatment, long covid and more. Bloomberg: Messy RSV Vaccine Rollout Puts Infants At Risk A hot new product has been sending parents of ...
Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here.
A new study is making the rounds in the antivax crankosphere. The study found that the modified mRNA used in the Pfizer ...
Argentine health authorities have approved the use of a Japanese vaccine against dengue that ... TAK-003, also known as Qdenga, received its first approval in August 2022 in Indonesia, followed ...
The ARVAC Cecilia Grierson represents “a safe, effective and quality tool,” according to Vizzotti Argentine health authorities Tuesday approved a booster Covid-19 vaccine fully developed in ...
A deal by the UK Health Security Agency (UKHSA) has been struck to produce millions of vaccines, should a flu pandemic occur. Manufacturer CSL Seqirus would be able to quickly produce more than ...
